Venn Life Sciences Holdings PLC Holding(s) in Company (1003E)
07 Mai 2013 - 9:36AM
UK Regulatory
TIDMVENN
RNS Number : 1003E
Venn Life Sciences Holdings PLC
07 May 2013
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
--------------------------------------------------
1. Identity of the issuer or the underlying Venn Life Sciences
issuer
of existing shares to which voting rights
are
attached: (ii)
---------------------------------------------------- ------------------------------------------
2 Reason for the notification (please tick the appropriate box or boxes):
------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights x
-------------------------------------------------------------------------------------- --------
An acquisition or disposal of qualifying financial instruments
which may result in the acquisition of shares already issued to
which voting rights are attached
-------------------------------------------------------------------------------------- --------
An acquisition or disposal of instruments with similar economic
effect to qualifying financial instruments
-------------------------------------------------------------------------------------- --------
An event changing the breakdown of voting rights
-------------------------------------------------------------------------------------- --------
Other (please
specify):
------------------ ------------------------------------------------------------------ --------
3. Full name of person(s) subject Killik & Co LLP
to the
notification obligation: (iii)
------------------------------------------ ----------------------------------------------------
4. Full name of shareholder(s) TDWCS LLP (on behalf of various discretionary
(if different from 3.):(iv) clients of Killik & Co LLP
------------------------------------------ ----------------------------------------------------
5. Date of the transaction and date 30(th) April 2013
on
which the threshold is crossed
or
reached: (v)
------------------------------------------ ----------------------------------------------------
6. Date on which issuer notified: 2(nd) May 2013
------------------------------------------ ----------------------------------------------------
7. Threshold(s) that is/are crossed Percentage holding over 3%
or
reached: (vi, vii)
------------------------------------------ ----------------------------------------------------
8. Notified details:
------------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
------------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the triggering
of to the triggering transaction
shares transaction
if possible
using
the ISIN
CODE
------------- ------------------------------------- ------------------------------------------------------------------
Number Number Number Number of voting % of voting rights
of of of shares rights (x)
Shares Voting
Rights
------------- ---------------- ------------------- ---------- ----------------------- -----------------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
------------- ------ ------ ------- ----- --- ---------- ------------ --------- ------------- --------------
Venn Life
Sciences Below 3% 676,082 676,082 3.36%
---------------- ------------------- ---------- ------------ --------- ------------- --------------
GB00B9275X97
------------- ------ ------ ------- ----- --- -------- ---- ------ --------- --- ---- -----------
B: Qualifying Financial Instruments
------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
------------------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date (xiii) Conversion Period rights that may rights
(xiv) be
acquired if the
instrument is
exercised/ converted.
----------------------- --------------- ---------------------------- -------------------------- --------------------
C: Financial Instruments with similar economic effect to Qualifying Financial
Instruments (xv, xvi)
------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
------------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting rights
financial price date (xvii) Conversion rights instrument (xix, xx)
instrument period refers to
(xviii)
--------------- -------------- -------------- --------------- --------------------------- -------------------------
Nominal Delta
--------------- -------------- -------------- --------------- --------------------------- ------------ -----------
Total (A+B+C)
------------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
-------------------------------------------------------------- --------------------------------------------------------
676,082 3.36%
-------------------------------------------------------------- --------------------------------------------------------
9. Chain of controlled undertakings through which the voting rights and/or
the
financial instruments are effectively held, if applicable: (xxi)
--------------------------------------------------------------------------------
Proxy Voting:
--------------------------------------------------------------------------------
10. Name of the proxy holder:
--------------------------------------------------- ---------------------------
11. Number of voting rights proxy holder will
cease
to hold:
--------------------------------------------------- ---------------------------
12. Date on which proxy holder will cease to
hold
voting rights:
--------------------------------------------------- ---------------------------
13. Additional information:
---------------------------------------- --------------------------------------
14. Contact name: Heidi Richer
---------------------------------------- --------------------------------------
15. Contact telephone number: 020 7337 0400
---------------------------------------- --------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEAXSXEDEDEEF
Hvivo (LSE:HVO)
Graphique Historique de l'Action
De Juil 2024 à Août 2024
Hvivo (LSE:HVO)
Graphique Historique de l'Action
De Août 2023 à Août 2024